Nabil Naser

Biographic Data

ID10274050
NAMENabil Naser
GIVEN NAMESNabil
FAMILY NAMENaser
SIGNATURENASER N
AFFILIATIONSUniversity Clinical Center Tuzla
VERIFIEDNo
TOTAL WORKS6
TOTAL CITATIONS0
AUTHOR COUNT6
EDITOR COUNT0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2023
H-INDEX0

  • Public Health Dimensions of Cardiovascular Diseases (CVD) Prevention and Control – Global Perspectives and Current Situation in the Federation of Bosnia and Herzegovina

    Open AccessAida Catak, Senka Dinarevic et al.ARTICLEMateria Socio Medica2023

    Background: Cardiovascular diseases (CVD) are the cause of 17 million deaths a year worldwide, of which 25% are sudden cardiac deaths (SCD). In Europe cardiovascular diseases (CVD) remains a leading cause of death in Europe accounting for 3.9 million deaths each year. Even with well-known risk factors and the current standards of health care, improvement of health and quality of life of CVD patients are still remains one of the biggest public hea…

  • The Effects of Single Pill Combinations on Adherence and Blood Pressure Control in Hypertensive Patients

    Open AccessNabil Naser, Zaim Jatić et al.ARTICLEMateria Socio Medica2022

    Background: Hypertension is the most important risk factor for cardiovascular morbidity and mortality. Blood pressure control rates are as low as 17% to 31% in patients diagnosed with hypertension in high-income countries; control rates are likely poorer in low- to middle- and low-income countries. Blood pressure control rates are as low as 17% to 31% in patients diagnosed with hypertension in high-income countries; control rates are likely poore…

  • Traditional Healing in Treatment of Diseasses in the Past in Bosnia and Herzegovina

    Open AccessIzet Masic, Nabil Naser et al.ARTICLEMateria Socio Medica2022

  • Public Health Aspects of Covid19 Infection with Focus on Cardiovascular Diseases

    Open AccessNabil Naser, Izet Masic et al.ARTICLEMateria Socio Medica2020

    INTRODUCTION: COVID-19 is the disease caused by an infection of the SARS-CoV-2 virus, first identified in the city of Wuhan, in China's Hubei province in December 2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease before the World Health Organization (WHO) declared the official name as COVID-19 in February 2020. AIM: The aim of this study is to search scientific literature in the biomedicine and analyzed…

  • The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation

    Nabil Naser, Mirza Dilic et al.ARTICLEMateria Socio Medica2017

    INTRODUCTION: Atrial fibrillation (AF) is the most common form of cardiac arrhythmia in clinical practice and its prevalence increases with age. Patients who develop AF also have cardiovascular risk factors, structural heart disease, and comorbidities, all of which can increase mortality. AF causes a significant economic burden with the increasing trend in AF prevalence and hospitalizations. RESEARCH OBJECTIVES: The objective of our study is to e…

  • Echocardiographic Assessment of Pulmonary Hypertension in Patients with Heart Diseases Compared with Cardiac Catheterization

    Nabil Naser, Marko Buksa et al.ARTICLEMateria Socio Medica2011

    Background: Pulmonary hypertension (PH) is a haemodinamic and pathophysiological condition defined as increase in mean Pulmonary Artery Pressure (PAP) ≥ 25mmHg at rest as sessed by right heart catheterization (RHC). Objective and purpose: The objective of this study is to determine, by investigating haemodynamic parameters of the pulmonary hypertension in congenital and left heart diseases, the linkage and diagnostic value of echocardiography in …